nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2D6—breast cancer	0.0817	0.389	CbGaD
Propafenone—CYP3A4—breast cancer	0.0701	0.334	CbGaD
Propafenone—ABCB1—breast cancer	0.0583	0.278	CbGaD
Propafenone—Dextropropoxyphene—Toremifene—breast cancer	0.0512	0.183	CrCrCtD
Propafenone—Phenoxybenzamine—Toremifene—breast cancer	0.0512	0.183	CrCrCtD
Propafenone—Benzphetamine—Toremifene—breast cancer	0.0358	0.128	CrCrCtD
Propafenone—Benzyl Benzoate—Toremifene—breast cancer	0.0332	0.119	CrCrCtD
Propafenone—Dextropropoxyphene—Tamoxifen—breast cancer	0.0321	0.115	CrCrCtD
Propafenone—Phenoxybenzamine—Tamoxifen—breast cancer	0.0321	0.115	CrCrCtD
Propafenone—Benzphetamine—Tamoxifen—breast cancer	0.0225	0.0806	CrCrCtD
Propafenone—Benzyl Benzoate—Tamoxifen—breast cancer	0.0208	0.0747	CrCrCtD
Propafenone—CYP1A2—Anastrozole—breast cancer	0.0177	0.0552	CbGbCtD
Propafenone—CYP1A2—Toremifene—breast cancer	0.0162	0.0505	CbGbCtD
Propafenone—CYP2C9—Anastrozole—breast cancer	0.0159	0.0498	CbGbCtD
Propafenone—CYP2C8—Lapatinib—breast cancer	0.0153	0.0476	CbGbCtD
Propafenone—ABCB1—Toremifene—breast cancer	0.0142	0.0442	CbGbCtD
Propafenone—CYP3A4—Exemestane—breast cancer	0.0122	0.0382	CbGbCtD
Propafenone—CYP2C9—Idarubicin—breast cancer	0.0121	0.0377	CbGbCtD
Propafenone—CYP2C8—Raloxifene—breast cancer	0.0116	0.0361	CbGbCtD
Propafenone—CYP2D6—Idarubicin—breast cancer	0.0111	0.0345	CbGbCtD
Propafenone—CYP3A4—Letrozole—breast cancer	0.0104	0.0325	CbGbCtD
Propafenone—ABCB1—Lapatinib—breast cancer	0.0103	0.0322	CbGbCtD
Propafenone—CYP3A4—Anastrozole—breast cancer	0.00927	0.0289	CbGbCtD
Propafenone—CYP3A4—Toremifene—breast cancer	0.00848	0.0265	CbGbCtD
Propafenone—CYP3A4—Fulvestrant—breast cancer	0.00788	0.0246	CbGbCtD
Propafenone—CYP2C8—Tamoxifen—breast cancer	0.00764	0.0238	CbGbCtD
Propafenone—CYP3A4—Thiotepa—breast cancer	0.00703	0.0219	CbGbCtD
Propafenone—CYP2C9—Capecitabine—breast cancer	0.00662	0.0207	CbGbCtD
Propafenone—CYP3A4—Ixabepilone—breast cancer	0.00643	0.0201	CbGbCtD
Propafenone—CYP3A4—Lapatinib—breast cancer	0.00619	0.0193	CbGbCtD
Propafenone—CYP2C8—Paclitaxel—breast cancer	0.00595	0.0185	CbGbCtD
Propafenone—CYP1A2—Tamoxifen—breast cancer	0.00591	0.0184	CbGbCtD
Propafenone—ABCB1—Vinorelbine—breast cancer	0.00573	0.0179	CbGbCtD
Propafenone—CYP2C8—Fluorouracil—breast cancer	0.00563	0.0176	CbGbCtD
Propafenone—CYP2D6—Vinorelbine—breast cancer	0.0054	0.0168	CbGbCtD
Propafenone—CYP2C9—Tamoxifen—breast cancer	0.00533	0.0166	CbGbCtD
Propafenone—ABCB1—Tamoxifen—breast cancer	0.00517	0.0161	CbGbCtD
Propafenone—ABCB1—Mitoxantrone—breast cancer	0.00504	0.0157	CbGbCtD
Propafenone—CYP2D6—Tamoxifen—breast cancer	0.00487	0.0152	CbGbCtD
Propafenone—CYP3A4—Raloxifene—breast cancer	0.00469	0.0146	CbGbCtD
Propafenone—ABCB1—Gemcitabine—breast cancer	0.00445	0.0139	CbGbCtD
Propafenone—CYP1A2—Fluorouracil—breast cancer	0.00436	0.0136	CbGbCtD
Propafenone—CYP2C9—Paclitaxel—breast cancer	0.00415	0.0129	CbGbCtD
Propafenone—ABCB1—Paclitaxel—breast cancer	0.00402	0.0126	CbGbCtD
Propafenone—ABCB1—Irinotecan—breast cancer	0.00397	0.0124	CbGbCtD
Propafenone—CYP2C9—Fluorouracil—breast cancer	0.00393	0.0122	CbGbCtD
Propafenone—ABCB1—Vinblastine—breast cancer	0.00353	0.011	CbGbCtD
Propafenone—CYP3A4—Vinorelbine—breast cancer	0.00343	0.0107	CbGbCtD
Propafenone—CYP2D6—Vinblastine—breast cancer	0.00333	0.0104	CbGbCtD
Propafenone—CYP3A4—Tamoxifen—breast cancer	0.0031	0.00966	CbGbCtD
Propafenone—CYP3A4—Mitoxantrone—breast cancer	0.00302	0.00943	CbGbCtD
Propafenone—ABCB1—Docetaxel—breast cancer	0.00291	0.00908	CbGbCtD
Propafenone—CYP3A4—Paclitaxel—breast cancer	0.00241	0.00752	CbGbCtD
Propafenone—CYP3A4—Irinotecan—breast cancer	0.00238	0.00742	CbGbCtD
Propafenone—ABCB1—Doxorubicin—breast cancer	0.00217	0.00677	CbGbCtD
Propafenone—CYP3A4—Vinblastine—breast cancer	0.00211	0.0066	CbGbCtD
Propafenone—ABCB1—Methotrexate—breast cancer	0.0021	0.00656	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—breast cancer	0.00204	0.00638	CbGbCtD
Propafenone—CYP3A4—Docetaxel—breast cancer	0.00174	0.00544	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—breast cancer	0.0013	0.00405	CbGbCtD
Propafenone—Carvedilol—HIF1A—breast cancer	0.000323	0.132	CrCbGaD
Propafenone—Mirabegron—BCHE—breast cancer	0.000212	0.0868	CrCbGaD
Propafenone—Benazepril—MTHFR—breast cancer	0.000172	0.0704	CrCbGaD
Propafenone—Carvedilol—VEGFA—breast cancer	0.00013	0.0533	CrCbGaD
Propafenone—Oxaprozin—PTGS1—breast cancer	0.000123	0.0506	CrCbGaD
Propafenone—Salsalate—PTGS1—breast cancer	0.000123	0.0506	CrCbGaD
Propafenone—Mirabegron—CYP2D6—breast cancer	0.000116	0.0476	CrCbGaD
Propafenone—Mirabegron—CYP3A4—breast cancer	9.97e-05	0.0409	CrCbGaD
Propafenone—Salmeterol—CYP3A4—breast cancer	9.12e-05	0.0374	CrCbGaD
Propafenone—Mirabegron—ALB—breast cancer	8.7e-05	0.0356	CrCbGaD
Propafenone—Mirabegron—ABCB1—breast cancer	8.3e-05	0.034	CrCbGaD
Propafenone—Salsalate—PTGS2—breast cancer	7.06e-05	0.0289	CrCbGaD
Propafenone—Oxaprozin—PTGS2—breast cancer	7.06e-05	0.0289	CrCbGaD
Propafenone—Carvedilol—PTGS1—breast cancer	6.87e-05	0.0281	CrCbGaD
Propafenone—Labetalol—CYP2D6—breast cancer	6.79e-05	0.0278	CrCbGaD
Propafenone—Carvedilol—CYP1A1—breast cancer	6.28e-05	0.0257	CrCbGaD
Propafenone—Propranolol—CYP1A1—breast cancer	4.78e-05	0.0196	CrCbGaD
Propafenone—Carvedilol—CYP2D6—breast cancer	4.68e-05	0.0192	CrCbGaD
Propafenone—Dextropropoxyphene—CYP2D6—breast cancer	4.3e-05	0.0176	CrCbGaD
Propafenone—Carvedilol—CYP3A4—breast cancer	4.01e-05	0.0164	CrCbGaD
Propafenone—Atomoxetine—CYP2D6—breast cancer	3.74e-05	0.0153	CrCbGaD
Propafenone—Dextropropoxyphene—CYP3A4—breast cancer	3.69e-05	0.0151	CrCbGaD
Propafenone—Fentanyl—CYP3A4—breast cancer	3.65e-05	0.015	CrCbGaD
Propafenone—Propranolol—CYP2D6—breast cancer	3.56e-05	0.0146	CrCbGaD
Propafenone—Carvedilol—ABCB1—breast cancer	3.34e-05	0.0137	CrCbGaD
Propafenone—Benzphetamine—CYP3A4—breast cancer	3.24e-05	0.0133	CrCbGaD
Propafenone—Atomoxetine—CYP3A4—breast cancer	3.21e-05	0.0132	CrCbGaD
Propafenone—Phenoxybenzamine—CYP3A4—breast cancer	3.09e-05	0.0127	CrCbGaD
Propafenone—Propranolol—CYP3A4—breast cancer	3.05e-05	0.0125	CrCbGaD
Propafenone—Fentanyl—ABCB1—breast cancer	3.04e-05	0.0125	CrCbGaD
Propafenone—CYP2C8—mammary gland—breast cancer	2.62e-05	0.0635	CbGeAlD
Propafenone—Propranolol—ABCB1—breast cancer	2.54e-05	0.0104	CrCbGaD
Propafenone—KCNH2—nipple—breast cancer	2.37e-05	0.0574	CbGeAlD
Propafenone—CYP2C9—mammary gland—breast cancer	2.33e-05	0.0564	CbGeAlD
Propafenone—CYP1A2—nipple—breast cancer	2.03e-05	0.0491	CbGeAlD
Propafenone—Hypoaesthesia—Doxorubicin—breast cancer	1.73e-05	0.000125	CcSEcCtD
Propafenone—Rash—Fluorouracil—breast cancer	1.73e-05	0.000125	CcSEcCtD
Propafenone—Dermatitis—Fluorouracil—breast cancer	1.72e-05	0.000125	CcSEcCtD
Propafenone—Paraesthesia—Capecitabine—breast cancer	1.72e-05	0.000125	CcSEcCtD
Propafenone—Decreased appetite—Docetaxel—breast cancer	1.72e-05	0.000125	CcSEcCtD
Propafenone—Hypersensitivity—Paclitaxel—breast cancer	1.72e-05	0.000125	CcSEcCtD
Propafenone—Headache—Fluorouracil—breast cancer	1.71e-05	0.000124	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—breast cancer	1.71e-05	0.000124	CcSEcCtD
Propafenone—Dysgeusia—Methotrexate—breast cancer	1.71e-05	0.000124	CcSEcCtD
Propafenone—Gastrointestinal disorder—Docetaxel—breast cancer	1.71e-05	0.000124	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—breast cancer	1.71e-05	0.000124	CcSEcCtD
Propafenone—Dyspnoea—Capecitabine—breast cancer	1.71e-05	0.000124	CcSEcCtD
Propafenone—Fatigue—Docetaxel—breast cancer	1.7e-05	0.000124	CcSEcCtD
Propafenone—Angiopathy—Epirubicin—breast cancer	1.7e-05	0.000123	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—breast cancer	1.7e-05	0.000123	CcSEcCtD
Propafenone—Nausea—Irinotecan—breast cancer	1.7e-05	0.000123	CcSEcCtD
Propafenone—Nausea—Mitoxantrone—breast cancer	1.7e-05	0.000123	CcSEcCtD
Propafenone—Immune system disorder—Epirubicin—breast cancer	1.69e-05	0.000123	CcSEcCtD
Propafenone—Mediastinal disorder—Epirubicin—breast cancer	1.69e-05	0.000123	CcSEcCtD
Propafenone—Constipation—Docetaxel—breast cancer	1.69e-05	0.000123	CcSEcCtD
Propafenone—Pain—Docetaxel—breast cancer	1.69e-05	0.000123	CcSEcCtD
Propafenone—ADRB1—adipose tissue—breast cancer	1.69e-05	0.0409	CbGeAlD
Propafenone—Dyspepsia—Capecitabine—breast cancer	1.68e-05	0.000122	CcSEcCtD
Propafenone—Arrhythmia—Epirubicin—breast cancer	1.68e-05	0.000122	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—breast cancer	1.67e-05	0.000121	CcSEcCtD
Propafenone—Asthenia—Paclitaxel—breast cancer	1.67e-05	0.000121	CcSEcCtD
Propafenone—Decreased appetite—Capecitabine—breast cancer	1.66e-05	0.000121	CcSEcCtD
Propafenone—Alopecia—Epirubicin—breast cancer	1.66e-05	0.00012	CcSEcCtD
Propafenone—Nausea—Gemcitabine—breast cancer	1.65e-05	0.00012	CcSEcCtD
Propafenone—Gastrointestinal disorder—Capecitabine—breast cancer	1.65e-05	0.00012	CcSEcCtD
Propafenone—Fatigue—Capecitabine—breast cancer	1.65e-05	0.00012	CcSEcCtD
Propafenone—Pruritus—Paclitaxel—breast cancer	1.65e-05	0.00012	CcSEcCtD
Propafenone—Vision blurred—Methotrexate—breast cancer	1.64e-05	0.000119	CcSEcCtD
Propafenone—Mental disorder—Epirubicin—breast cancer	1.64e-05	0.000119	CcSEcCtD
Propafenone—Pain—Capecitabine—breast cancer	1.64e-05	0.000119	CcSEcCtD
Propafenone—Constipation—Capecitabine—breast cancer	1.64e-05	0.000119	CcSEcCtD
Propafenone—Malnutrition—Epirubicin—breast cancer	1.63e-05	0.000118	CcSEcCtD
Propafenone—Erythema—Epirubicin—breast cancer	1.63e-05	0.000118	CcSEcCtD
Propafenone—Feeling abnormal—Docetaxel—breast cancer	1.63e-05	0.000118	CcSEcCtD
Propafenone—Nausea—Fluorouracil—breast cancer	1.63e-05	0.000118	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—breast cancer	1.62e-05	0.000118	CcSEcCtD
Propafenone—Ill-defined disorder—Methotrexate—breast cancer	1.62e-05	0.000117	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—breast cancer	1.62e-05	0.000117	CcSEcCtD
Propafenone—Gastrointestinal pain—Docetaxel—breast cancer	1.62e-05	0.000117	CcSEcCtD
Propafenone—Anaemia—Methotrexate—breast cancer	1.61e-05	0.000117	CcSEcCtD
Propafenone—Flushing—Doxorubicin—breast cancer	1.61e-05	0.000117	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—breast cancer	1.61e-05	0.000117	CcSEcCtD
Propafenone—Flatulence—Epirubicin—breast cancer	1.61e-05	0.000117	CcSEcCtD
Propafenone—Tension—Epirubicin—breast cancer	1.6e-05	0.000116	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—breast cancer	1.6e-05	0.000116	CcSEcCtD
Propafenone—Diarrhoea—Paclitaxel—breast cancer	1.59e-05	0.000116	CcSEcCtD
Propafenone—Nervousness—Epirubicin—breast cancer	1.59e-05	0.000115	CcSEcCtD
Propafenone—Feeling abnormal—Capecitabine—breast cancer	1.58e-05	0.000114	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—breast cancer	1.57e-05	0.000114	CcSEcCtD
Propafenone—Malaise—Methotrexate—breast cancer	1.57e-05	0.000114	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—breast cancer	1.57e-05	0.000114	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—breast cancer	1.57e-05	0.000114	CcSEcCtD
Propafenone—Vertigo—Methotrexate—breast cancer	1.57e-05	0.000114	CcSEcCtD
Propafenone—Gastrointestinal pain—Capecitabine—breast cancer	1.56e-05	0.000113	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—breast cancer	1.56e-05	0.000113	CcSEcCtD
Propafenone—Body temperature increased—Docetaxel—breast cancer	1.56e-05	0.000113	CcSEcCtD
Propafenone—Abdominal pain—Docetaxel—breast cancer	1.56e-05	0.000113	CcSEcCtD
Propafenone—Leukopenia—Methotrexate—breast cancer	1.56e-05	0.000113	CcSEcCtD
Propafenone—ADRB1—female reproductive system—breast cancer	1.55e-05	0.0376	CbGeAlD
Propafenone—Arrhythmia—Doxorubicin—breast cancer	1.55e-05	0.000112	CcSEcCtD
Propafenone—Dizziness—Paclitaxel—breast cancer	1.54e-05	0.000112	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—breast cancer	1.54e-05	0.000112	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—breast cancer	1.53e-05	0.000111	CcSEcCtD
Propafenone—Cough—Methotrexate—breast cancer	1.52e-05	0.00011	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—breast cancer	1.52e-05	0.00011	CcSEcCtD
Propafenone—Urticaria—Capecitabine—breast cancer	1.52e-05	0.00011	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—breast cancer	1.51e-05	0.00011	CcSEcCtD
Propafenone—Body temperature increased—Capecitabine—breast cancer	1.51e-05	0.00011	CcSEcCtD
Propafenone—Abdominal pain—Capecitabine—breast cancer	1.51e-05	0.00011	CcSEcCtD
Propafenone—Convulsion—Methotrexate—breast cancer	1.51e-05	0.00011	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—breast cancer	1.51e-05	0.00011	CcSEcCtD
Propafenone—Erythema—Doxorubicin—breast cancer	1.51e-05	0.00011	CcSEcCtD
Propafenone—Anaemia—Epirubicin—breast cancer	1.51e-05	0.000109	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—breast cancer	1.49e-05	0.000108	CcSEcCtD
Propafenone—Myalgia—Methotrexate—breast cancer	1.49e-05	0.000108	CcSEcCtD
Propafenone—Chest pain—Methotrexate—breast cancer	1.49e-05	0.000108	CcSEcCtD
Propafenone—Tension—Doxorubicin—breast cancer	1.48e-05	0.000108	CcSEcCtD
Propafenone—Vomiting—Paclitaxel—breast cancer	1.48e-05	0.000108	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—breast cancer	1.48e-05	0.000107	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.47e-05	0.000107	CcSEcCtD
Propafenone—Malaise—Epirubicin—breast cancer	1.47e-05	0.000107	CcSEcCtD
Propafenone—Rash—Paclitaxel—breast cancer	1.47e-05	0.000107	CcSEcCtD
Propafenone—Dermatitis—Paclitaxel—breast cancer	1.47e-05	0.000107	CcSEcCtD
Propafenone—Discomfort—Methotrexate—breast cancer	1.47e-05	0.000106	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—breast cancer	1.47e-05	0.000106	CcSEcCtD
Propafenone—Vertigo—Epirubicin—breast cancer	1.47e-05	0.000106	CcSEcCtD
Propafenone—Syncope—Epirubicin—breast cancer	1.46e-05	0.000106	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—breast cancer	1.46e-05	0.000106	CcSEcCtD
Propafenone—Headache—Paclitaxel—breast cancer	1.46e-05	0.000106	CcSEcCtD
Propafenone—Hypersensitivity—Docetaxel—breast cancer	1.46e-05	0.000106	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—breast cancer	1.45e-05	0.000105	CcSEcCtD
Propafenone—Palpitations—Epirubicin—breast cancer	1.44e-05	0.000105	CcSEcCtD
Propafenone—Confusional state—Methotrexate—breast cancer	1.44e-05	0.000104	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—breast cancer	1.43e-05	0.000104	CcSEcCtD
Propafenone—KCNH2—endometrium—breast cancer	1.43e-05	0.0346	CbGeAlD
Propafenone—Cough—Epirubicin—breast cancer	1.42e-05	0.000103	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—breast cancer	1.42e-05	0.000103	CcSEcCtD
Propafenone—Asthenia—Docetaxel—breast cancer	1.42e-05	0.000103	CcSEcCtD
Propafenone—Convulsion—Epirubicin—breast cancer	1.41e-05	0.000103	CcSEcCtD
Propafenone—Infection—Methotrexate—breast cancer	1.41e-05	0.000103	CcSEcCtD
Propafenone—Hypertension—Epirubicin—breast cancer	1.41e-05	0.000102	CcSEcCtD
Propafenone—Hypersensitivity—Capecitabine—breast cancer	1.41e-05	0.000102	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—breast cancer	1.4e-05	0.000102	CcSEcCtD
Propafenone—Pruritus—Docetaxel—breast cancer	1.4e-05	0.000101	CcSEcCtD
Propafenone—Nervous system disorder—Methotrexate—breast cancer	1.4e-05	0.000101	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—breast cancer	1.4e-05	0.000101	CcSEcCtD
Propafenone—Thrombocytopenia—Methotrexate—breast cancer	1.39e-05	0.000101	CcSEcCtD
Propafenone—Myalgia—Epirubicin—breast cancer	1.39e-05	0.000101	CcSEcCtD
Propafenone—Chest pain—Epirubicin—breast cancer	1.39e-05	0.000101	CcSEcCtD
Propafenone—Anxiety—Epirubicin—breast cancer	1.39e-05	0.000101	CcSEcCtD
Propafenone—Nausea—Paclitaxel—breast cancer	1.38e-05	0.0001	CcSEcCtD
Propafenone—Skin disorder—Methotrexate—breast cancer	1.38e-05	0.0001	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.38e-05	0.0001	CcSEcCtD
Propafenone—Hyperhidrosis—Methotrexate—breast cancer	1.38e-05	9.99e-05	CcSEcCtD
Propafenone—Discomfort—Epirubicin—breast cancer	1.37e-05	9.96e-05	CcSEcCtD
Propafenone—Asthenia—Capecitabine—breast cancer	1.37e-05	9.96e-05	CcSEcCtD
Propafenone—Malaise—Doxorubicin—breast cancer	1.36e-05	9.89e-05	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—breast cancer	1.36e-05	9.86e-05	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—breast cancer	1.36e-05	9.85e-05	CcSEcCtD
Propafenone—Anorexia—Methotrexate—breast cancer	1.36e-05	9.85e-05	CcSEcCtD
Propafenone—Syncope—Doxorubicin—breast cancer	1.35e-05	9.83e-05	CcSEcCtD
Propafenone—Pruritus—Capecitabine—breast cancer	1.35e-05	9.82e-05	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—breast cancer	1.35e-05	9.81e-05	CcSEcCtD
Propafenone—Diarrhoea—Docetaxel—breast cancer	1.35e-05	9.81e-05	CcSEcCtD
Propafenone—Confusional state—Epirubicin—breast cancer	1.34e-05	9.75e-05	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—breast cancer	1.33e-05	9.69e-05	CcSEcCtD
Propafenone—Oedema—Epirubicin—breast cancer	1.33e-05	9.67e-05	CcSEcCtD
Propafenone—Hypotension—Methotrexate—breast cancer	1.33e-05	9.65e-05	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—breast cancer	1.33e-05	9.63e-05	CcSEcCtD
Propafenone—Infection—Epirubicin—breast cancer	1.32e-05	9.61e-05	CcSEcCtD
Propafenone—Cough—Doxorubicin—breast cancer	1.32e-05	9.57e-05	CcSEcCtD
Propafenone—KCNH2—uterus—breast cancer	1.32e-05	0.0319	CbGeAlD
Propafenone—ADRB1—endocrine gland—breast cancer	1.31e-05	0.0318	CbGeAlD
Propafenone—Shock—Epirubicin—breast cancer	1.31e-05	9.51e-05	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—breast cancer	1.31e-05	9.5e-05	CcSEcCtD
Propafenone—CYP2C8—endometrium—breast cancer	1.31e-05	0.0317	CbGeAlD
Propafenone—Diarrhoea—Capecitabine—breast cancer	1.31e-05	9.5e-05	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—breast cancer	1.31e-05	9.48e-05	CcSEcCtD
Propafenone—Dizziness—Docetaxel—breast cancer	1.31e-05	9.48e-05	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—breast cancer	1.3e-05	9.47e-05	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—breast cancer	1.3e-05	9.46e-05	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—breast cancer	1.3e-05	9.44e-05	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Methotrexate—breast cancer	1.3e-05	9.41e-05	CcSEcCtD
Propafenone—KCNH2—pituitary gland—breast cancer	1.29e-05	0.0314	CbGeAlD
Propafenone—Skin disorder—Epirubicin—breast cancer	1.29e-05	9.39e-05	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—breast cancer	1.29e-05	9.35e-05	CcSEcCtD
Propafenone—Insomnia—Methotrexate—breast cancer	1.29e-05	9.34e-05	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—breast cancer	1.29e-05	9.33e-05	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—breast cancer	1.29e-05	9.33e-05	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—breast cancer	1.28e-05	9.3e-05	CcSEcCtD
Propafenone—Paraesthesia—Methotrexate—breast cancer	1.28e-05	9.28e-05	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.28e-05	9.27e-05	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—breast cancer	1.27e-05	9.22e-05	CcSEcCtD
Propafenone—Anorexia—Epirubicin—breast cancer	1.27e-05	9.22e-05	CcSEcCtD
Propafenone—Dyspnoea—Methotrexate—breast cancer	1.27e-05	9.21e-05	CcSEcCtD
Propafenone—Somnolence—Methotrexate—breast cancer	1.27e-05	9.18e-05	CcSEcCtD
Propafenone—Dizziness—Capecitabine—breast cancer	1.26e-05	9.18e-05	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—breast cancer	1.26e-05	9.13e-05	CcSEcCtD
Propafenone—Vomiting—Docetaxel—breast cancer	1.26e-05	9.11e-05	CcSEcCtD
Propafenone—Dyspepsia—Methotrexate—breast cancer	1.25e-05	9.09e-05	CcSEcCtD
Propafenone—Rash—Docetaxel—breast cancer	1.25e-05	9.04e-05	CcSEcCtD
Propafenone—Hypotension—Epirubicin—breast cancer	1.24e-05	9.03e-05	CcSEcCtD
Propafenone—Dermatitis—Docetaxel—breast cancer	1.24e-05	9.03e-05	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—breast cancer	1.24e-05	9.02e-05	CcSEcCtD
Propafenone—Decreased appetite—Methotrexate—breast cancer	1.24e-05	8.98e-05	CcSEcCtD
Propafenone—Headache—Docetaxel—breast cancer	1.24e-05	8.98e-05	CcSEcCtD
Propafenone—Oedema—Doxorubicin—breast cancer	1.23e-05	8.95e-05	CcSEcCtD
Propafenone—Gastrointestinal disorder—Methotrexate—breast cancer	1.23e-05	8.92e-05	CcSEcCtD
Propafenone—Fatigue—Methotrexate—breast cancer	1.23e-05	8.91e-05	CcSEcCtD
Propafenone—Infection—Doxorubicin—breast cancer	1.22e-05	8.89e-05	CcSEcCtD
Propafenone—Pain—Methotrexate—breast cancer	1.22e-05	8.83e-05	CcSEcCtD
Propafenone—Vomiting—Capecitabine—breast cancer	1.22e-05	8.82e-05	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—breast cancer	1.21e-05	8.81e-05	CcSEcCtD
Propafenone—Shock—Doxorubicin—breast cancer	1.21e-05	8.8e-05	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—breast cancer	1.21e-05	8.77e-05	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—breast cancer	1.21e-05	8.76e-05	CcSEcCtD
Propafenone—Rash—Capecitabine—breast cancer	1.21e-05	8.75e-05	CcSEcCtD
Propafenone—Insomnia—Epirubicin—breast cancer	1.21e-05	8.74e-05	CcSEcCtD
Propafenone—Dermatitis—Capecitabine—breast cancer	1.2e-05	8.74e-05	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—breast cancer	1.2e-05	8.73e-05	CcSEcCtD
Propafenone—Headache—Capecitabine—breast cancer	1.2e-05	8.69e-05	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—breast cancer	1.2e-05	8.69e-05	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—breast cancer	1.2e-05	8.68e-05	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—breast cancer	1.19e-05	8.65e-05	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—breast cancer	1.19e-05	8.62e-05	CcSEcCtD
Propafenone—KCNH2—female reproductive system—breast cancer	1.18e-05	0.0287	CbGeAlD
Propafenone—Somnolence—Epirubicin—breast cancer	1.18e-05	8.6e-05	CcSEcCtD
Propafenone—CYP2C8—pituitary gland—breast cancer	1.18e-05	0.0287	CbGeAlD
Propafenone—Anorexia—Doxorubicin—breast cancer	1.18e-05	8.53e-05	CcSEcCtD
Propafenone—Nausea—Docetaxel—breast cancer	1.17e-05	8.51e-05	CcSEcCtD
Propafenone—Feeling abnormal—Methotrexate—breast cancer	1.17e-05	8.51e-05	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—breast cancer	1.17e-05	8.51e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Methotrexate—breast cancer	1.16e-05	8.45e-05	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—breast cancer	1.16e-05	8.4e-05	CcSEcCtD
Propafenone—KCNH2—adrenal gland—breast cancer	1.16e-05	0.028	CbGeAlD
Propafenone—Hypotension—Doxorubicin—breast cancer	1.15e-05	8.36e-05	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—breast cancer	1.15e-05	8.35e-05	CcSEcCtD
Propafenone—Fatigue—Epirubicin—breast cancer	1.15e-05	8.34e-05	CcSEcCtD
Propafenone—Constipation—Epirubicin—breast cancer	1.14e-05	8.27e-05	CcSEcCtD
Propafenone—Pain—Epirubicin—breast cancer	1.14e-05	8.27e-05	CcSEcCtD
Propafenone—Nausea—Capecitabine—breast cancer	1.14e-05	8.24e-05	CcSEcCtD
Propafenone—Urticaria—Methotrexate—breast cancer	1.13e-05	8.21e-05	CcSEcCtD
Propafenone—Abdominal pain—Methotrexate—breast cancer	1.13e-05	8.17e-05	CcSEcCtD
Propafenone—Body temperature increased—Methotrexate—breast cancer	1.13e-05	8.17e-05	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.12e-05	8.15e-05	CcSEcCtD
Propafenone—KCNH2—bone marrow—breast cancer	1.12e-05	0.0271	CbGeAlD
Propafenone—Insomnia—Doxorubicin—breast cancer	1.12e-05	8.09e-05	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—breast cancer	1.11e-05	8.03e-05	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—breast cancer	1.1e-05	7.98e-05	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—breast cancer	1.1e-05	7.97e-05	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—breast cancer	1.1e-05	7.95e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—breast cancer	1.09e-05	7.91e-05	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—breast cancer	1.09e-05	7.87e-05	CcSEcCtD
Propafenone—CYP2C8—female reproductive system—breast cancer	1.08e-05	0.0263	CbGeAlD
Propafenone—KCNH2—female gonad—breast cancer	1.08e-05	0.0261	CbGeAlD
Propafenone—Decreased appetite—Doxorubicin—breast cancer	1.07e-05	7.78e-05	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—breast cancer	1.06e-05	7.72e-05	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—breast cancer	1.06e-05	7.71e-05	CcSEcCtD
Propafenone—Urticaria—Epirubicin—breast cancer	1.06e-05	7.68e-05	CcSEcCtD
Propafenone—Pain—Doxorubicin—breast cancer	1.05e-05	7.65e-05	CcSEcCtD
Propafenone—Constipation—Doxorubicin—breast cancer	1.05e-05	7.65e-05	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—breast cancer	1.05e-05	7.64e-05	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—breast cancer	1.05e-05	7.64e-05	CcSEcCtD
Propafenone—Hypersensitivity—Methotrexate—breast cancer	1.05e-05	7.61e-05	CcSEcCtD
Propafenone—Asthenia—Methotrexate—breast cancer	1.02e-05	7.41e-05	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—breast cancer	1.02e-05	7.37e-05	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—breast cancer	1.01e-05	7.32e-05	CcSEcCtD
Propafenone—Pruritus—Methotrexate—breast cancer	1.01e-05	7.31e-05	CcSEcCtD
Propafenone—KCNH2—endocrine gland—breast cancer	1e-05	0.0243	CbGeAlD
Propafenone—Hypersensitivity—Epirubicin—breast cancer	9.82e-06	7.12e-05	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—breast cancer	9.79e-06	7.11e-05	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—breast cancer	9.75e-06	7.07e-05	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—breast cancer	9.75e-06	7.07e-05	CcSEcCtD
Propafenone—Diarrhoea—Methotrexate—breast cancer	9.74e-06	7.07e-05	CcSEcCtD
Propafenone—CYP2C9—female reproductive system—breast cancer	9.63e-06	0.0233	CbGeAlD
Propafenone—Asthenia—Epirubicin—breast cancer	9.56e-06	6.94e-05	CcSEcCtD
Propafenone—Pruritus—Epirubicin—breast cancer	9.43e-06	6.84e-05	CcSEcCtD
Propafenone—Dizziness—Methotrexate—breast cancer	9.41e-06	6.83e-05	CcSEcCtD
Propafenone—CYP2C8—endocrine gland—breast cancer	9.17e-06	0.0222	CbGeAlD
Propafenone—Diarrhoea—Epirubicin—breast cancer	9.12e-06	6.62e-05	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—breast cancer	9.08e-06	6.59e-05	CcSEcCtD
Propafenone—Vomiting—Methotrexate—breast cancer	9.05e-06	6.57e-05	CcSEcCtD
Propafenone—Rash—Methotrexate—breast cancer	8.98e-06	6.51e-05	CcSEcCtD
Propafenone—Dermatitis—Methotrexate—breast cancer	8.97e-06	6.51e-05	CcSEcCtD
Propafenone—Headache—Methotrexate—breast cancer	8.92e-06	6.47e-05	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—breast cancer	8.84e-06	6.42e-05	CcSEcCtD
Propafenone—Dizziness—Epirubicin—breast cancer	8.81e-06	6.39e-05	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—breast cancer	8.72e-06	6.33e-05	CcSEcCtD
Propafenone—CYP1A2—endocrine gland—breast cancer	8.58e-06	0.0208	CbGeAlD
Propafenone—ABCB1—embryo—breast cancer	8.57e-06	0.0208	CbGeAlD
Propafenone—Vomiting—Epirubicin—breast cancer	8.47e-06	6.15e-05	CcSEcCtD
Propafenone—Nausea—Methotrexate—breast cancer	8.46e-06	6.14e-05	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—breast cancer	8.43e-06	6.12e-05	CcSEcCtD
Propafenone—Rash—Epirubicin—breast cancer	8.4e-06	6.1e-05	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—breast cancer	8.39e-06	6.09e-05	CcSEcCtD
Propafenone—Headache—Epirubicin—breast cancer	8.35e-06	6.06e-05	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—breast cancer	8.15e-06	5.92e-05	CcSEcCtD
Propafenone—CYP2C9—endocrine gland—breast cancer	8.15e-06	0.0197	CbGeAlD
Propafenone—Nausea—Epirubicin—breast cancer	7.91e-06	5.74e-05	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—breast cancer	7.84e-06	5.69e-05	CcSEcCtD
Propafenone—Rash—Doxorubicin—breast cancer	7.77e-06	5.64e-05	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—breast cancer	7.77e-06	5.64e-05	CcSEcCtD
Propafenone—Headache—Doxorubicin—breast cancer	7.72e-06	5.6e-05	CcSEcCtD
Propafenone—CYP3A4—female reproductive system—breast cancer	7.34e-06	0.0178	CbGeAlD
Propafenone—Nausea—Doxorubicin—breast cancer	7.32e-06	5.31e-05	CcSEcCtD
Propafenone—CYP2D6—female reproductive system—breast cancer	7.23e-06	0.0175	CbGeAlD
Propafenone—ABCB1—epithelium—breast cancer	7e-06	0.0169	CbGeAlD
Propafenone—KCNH2—lymph node—breast cancer	6.93e-06	0.0168	CbGeAlD
Propafenone—CYP2D6—female gonad—breast cancer	6.57e-06	0.0159	CbGeAlD
Propafenone—ABCB1—endometrium—breast cancer	6.27e-06	0.0152	CbGeAlD
Propafenone—CYP3A4—endocrine gland—breast cancer	6.21e-06	0.0151	CbGeAlD
Propafenone—CYP2D6—endocrine gland—breast cancer	6.11e-06	0.0148	CbGeAlD
Propafenone—ABCB1—uterus—breast cancer	5.78e-06	0.014	CbGeAlD
Propafenone—ABCB1—pituitary gland—breast cancer	5.68e-06	0.0138	CbGeAlD
Propafenone—ABCB1—adipose tissue—breast cancer	5.65e-06	0.0137	CbGeAlD
Propafenone—ABCB1—female reproductive system—breast cancer	5.2e-06	0.0126	CbGeAlD
Propafenone—ABCB1—adrenal gland—breast cancer	5.07e-06	0.0123	CbGeAlD
Propafenone—ABCB1—bone marrow—breast cancer	4.91e-06	0.0119	CbGeAlD
Propafenone—ABCB1—female gonad—breast cancer	4.73e-06	0.0115	CbGeAlD
Propafenone—ABCB1—endocrine gland—breast cancer	4.4e-06	0.0107	CbGeAlD
Propafenone—ABCB1—lymph node—breast cancer	3.04e-06	0.00737	CbGeAlD
Propafenone—ADRB1—Signaling Pathways—APC—breast cancer	2.65e-06	5.34e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CG—breast cancer	2.65e-06	5.34e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KIT—breast cancer	2.65e-06	5.34e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.65e-06	5.34e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NCOA1—breast cancer	2.65e-06	5.34e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP3A4—breast cancer	2.64e-06	5.32e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP17A1—breast cancer	2.64e-06	5.31e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.63e-06	5.29e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCB1—breast cancer	2.63e-06	5.29e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGF—breast cancer	2.62e-06	5.28e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1B1—breast cancer	2.62e-06	5.28e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP19A1—breast cancer	2.61e-06	5.26e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—STK11—breast cancer	2.61e-06	5.26e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO1—breast cancer	2.61e-06	5.26e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS1—breast cancer	2.61e-06	5.26e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.6e-06	5.24e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1B1—breast cancer	2.6e-06	5.23e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—TYMS—breast cancer	2.58e-06	5.2e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.57e-06	5.17e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.57e-06	5.17e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2D6—breast cancer	2.56e-06	5.15e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NCOR1—breast cancer	2.55e-06	5.14e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.55e-06	5.14e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—breast cancer	2.55e-06	5.14e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.55e-06	5.13e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK3—breast cancer	2.54e-06	5.12e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NCOA2—breast cancer	2.51e-06	5.06e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NCOA1—breast cancer	2.5e-06	5.03e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BRAF—breast cancer	2.5e-06	5.02e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NCOA1—breast cancer	2.48e-06	4.99e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—STK11—breast cancer	2.46e-06	4.96e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP19A1—breast cancer	2.46e-06	4.96e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GPX1—breast cancer	2.44e-06	4.92e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—STK11—breast cancer	2.44e-06	4.92e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP19A1—breast cancer	2.44e-06	4.92e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—FASN—breast cancer	2.44e-06	4.91e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MED12—breast cancer	2.43e-06	4.9e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—DPYD—breast cancer	2.43e-06	4.9e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1—breast cancer	2.43e-06	4.89e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—COMT—breast cancer	2.43e-06	4.89e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT2—breast cancer	2.43e-06	4.89e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—BCHE—breast cancer	2.43e-06	4.89e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTP1—breast cancer	2.42e-06	4.87e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1A1—breast cancer	2.42e-06	4.87e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—breast cancer	2.42e-06	4.87e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ERCC2—breast cancer	2.4e-06	4.83e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC5A5—breast cancer	2.4e-06	4.83e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDOA—breast cancer	2.39e-06	4.82e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—HMOX1—breast cancer	2.39e-06	4.8e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ITPR1—breast cancer	2.38e-06	4.79e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CD—breast cancer	2.33e-06	4.7e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOA3—breast cancer	2.32e-06	4.68e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC2A1—breast cancer	2.32e-06	4.66e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NQO1—breast cancer	2.32e-06	4.66e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	2.31e-06	4.65e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SERPINE1—breast cancer	2.31e-06	4.65e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC2A2—breast cancer	2.31e-06	4.65e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.29e-06	4.62e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—COMT—breast cancer	2.29e-06	4.61e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—KRAS—breast cancer	2.28e-06	4.6e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTP1—breast cancer	2.28e-06	4.59e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—COMT—breast cancer	2.27e-06	4.57e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.27e-06	4.56e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCG2—breast cancer	2.26e-06	4.55e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTR—breast cancer	2.26e-06	4.55e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CPT1A—breast cancer	2.26e-06	4.55e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTP1—breast cancer	2.26e-06	4.55e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP3A4—breast cancer	2.26e-06	4.55e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—MTHFR—breast cancer	2.25e-06	4.54e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—TYMS—breast cancer	2.25e-06	4.53e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—HMOX1—breast cancer	2.25e-06	4.53e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.25e-06	4.52e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ITPR1—breast cancer	2.24e-06	4.52e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—HMOX1—breast cancer	2.23e-06	4.49e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ITPR1—breast cancer	2.22e-06	4.48e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NCOR1—breast cancer	2.22e-06	4.48e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—breast cancer	2.22e-06	4.48e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PLA2G4A—breast cancer	2.22e-06	4.48e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1B1—breast cancer	2.22e-06	4.47e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HPGDS—breast cancer	2.22e-06	4.46e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOS3—breast cancer	2.2e-06	4.44e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HBA1—breast cancer	2.2e-06	4.43e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.18e-06	4.38e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCB1—breast cancer	2.16e-06	4.34e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ACHE—breast cancer	2.15e-06	4.33e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—breast cancer	2.15e-06	4.33e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCB1—breast cancer	2.14e-06	4.31e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GPX1—breast cancer	2.13e-06	4.29e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—TYMS—breast cancer	2.12e-06	4.27e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NCOA1—breast cancer	2.12e-06	4.26e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A1—breast cancer	2.11e-06	4.24e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—TYMS—breast cancer	2.1e-06	4.23e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	2.1e-06	4.23e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.09e-06	4.22e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NCOR1—breast cancer	2.09e-06	4.22e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—breast cancer	2.09e-06	4.22e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MDM2—breast cancer	2.09e-06	4.21e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ERCC2—breast cancer	2.09e-06	4.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—STK11—breast cancer	2.09e-06	4.2e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP19A1—breast cancer	2.09e-06	4.2e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAF1—breast cancer	2.08e-06	4.19e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CAV1—breast cancer	2.08e-06	4.19e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NCOR1—breast cancer	2.08e-06	4.18e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.08e-06	4.18e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—breast cancer	2.08e-06	4.18e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RELA—breast cancer	2.07e-06	4.18e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB2—breast cancer	2.06e-06	4.15e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP17A1—breast cancer	2.04e-06	4.1e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MTOR—breast cancer	2.03e-06	4.1e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CB—breast cancer	2.03e-06	4.1e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO1—breast cancer	2.01e-06	4.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS1—breast cancer	2.01e-06	4.06e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPX1—breast cancer	2.01e-06	4.04e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPX1—breast cancer	1.99e-06	4e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.99e-06	4e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A1—breast cancer	1.99e-06	4e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2D6—breast cancer	1.98e-06	3.98e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ERCC2—breast cancer	1.97e-06	3.96e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A1—breast cancer	1.97e-06	3.96e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—MTHFR—breast cancer	1.96e-06	3.96e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.96e-06	3.94e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CXCL8—breast cancer	1.95e-06	3.94e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ERCC2—breast cancer	1.95e-06	3.93e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—HRAS—breast cancer	1.94e-06	3.91e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—COMT—breast cancer	1.94e-06	3.91e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOA2—breast cancer	1.94e-06	3.9e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTP1—breast cancer	1.93e-06	3.89e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1B—breast cancer	1.91e-06	3.84e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—HMOX1—breast cancer	1.9e-06	3.83e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ITPR1—breast cancer	1.9e-06	3.83e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CG—breast cancer	1.89e-06	3.81e-05	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—AKT1—breast cancer	1.89e-06	3.8e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—FASN—breast cancer	1.88e-06	3.79e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—BCHE—breast cancer	1.87e-06	3.77e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CASP3—breast cancer	1.87e-06	3.77e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—breast cancer	1.87e-06	3.76e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL6—breast cancer	1.86e-06	3.74e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—MTHFR—breast cancer	1.85e-06	3.73e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC5A5—breast cancer	1.85e-06	3.72e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—MTHFR—breast cancer	1.84e-06	3.69e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCB1—breast cancer	1.83e-06	3.68e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—breast cancer	1.82e-06	3.67e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JUN—breast cancer	1.82e-06	3.66e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CAV1—breast cancer	1.81e-06	3.65e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CTNNB1—breast cancer	1.8e-06	3.63e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—TYMS—breast cancer	1.8e-06	3.61e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC2A1—breast cancer	1.79e-06	3.6e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NQO1—breast cancer	1.79e-06	3.6e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—breast cancer	1.77e-06	3.57e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.77e-06	3.57e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NCOR1—breast cancer	1.77e-06	3.57e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MMP9—breast cancer	1.77e-06	3.56e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1A—breast cancer	1.76e-06	3.55e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTEN—breast cancer	1.76e-06	3.54e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK8—breast cancer	1.72e-06	3.46e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—AKT1—breast cancer	1.71e-06	3.45e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1B1—breast cancer	1.71e-06	3.45e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CAV1—breast cancer	1.71e-06	3.44e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPX1—breast cancer	1.7e-06	3.42e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CAV1—breast cancer	1.69e-06	3.41e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1A1—breast cancer	1.68e-06	3.39e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.68e-06	3.38e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ERCC2—breast cancer	1.67e-06	3.36e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CD—breast cancer	1.67e-06	3.35e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CG—breast cancer	1.65e-06	3.32e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ALB—breast cancer	1.64e-06	3.31e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOA1—breast cancer	1.63e-06	3.29e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SRC—breast cancer	1.63e-06	3.28e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.62e-06	3.26e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—STK11—breast cancer	1.61e-06	3.24e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP19A1—breast cancer	1.61e-06	3.24e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—breast cancer	1.59e-06	3.2e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—NOS3—breast cancer	1.57e-06	3.17e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—breast cancer	1.57e-06	3.17e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—MTHFR—breast cancer	1.57e-06	3.16e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CG—breast cancer	1.56e-06	3.13e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CG—breast cancer	1.54e-06	3.1e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK3—breast cancer	1.5e-06	3.02e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—COMT—breast cancer	1.5e-06	3.01e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTP1—breast cancer	1.49e-06	3e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—HMOX1—breast cancer	1.47e-06	2.96e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ITPR1—breast cancer	1.47e-06	2.95e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—breast cancer	1.46e-06	2.94e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TGFB1—breast cancer	1.46e-06	2.93e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CB—breast cancer	1.45e-06	2.92e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CD—breast cancer	1.45e-06	2.92e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CAV1—breast cancer	1.45e-06	2.91e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—breast cancer	1.44e-06	2.9e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALB—breast cancer	1.43e-06	2.88e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—breast cancer	1.43e-06	2.88e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCB1—breast cancer	1.41e-06	2.84e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—TYMS—breast cancer	1.39e-06	2.79e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.38e-06	2.78e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—NOS3—breast cancer	1.37e-06	2.76e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—breast cancer	1.37e-06	2.76e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NCOR1—breast cancer	1.37e-06	2.76e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.37e-06	2.76e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CD—breast cancer	1.37e-06	2.75e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CD—breast cancer	1.36e-06	2.73e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KRAS—breast cancer	1.35e-06	2.72e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALB—breast cancer	1.35e-06	2.72e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALB—breast cancer	1.34e-06	2.69e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CG—breast cancer	1.32e-06	2.65e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPX1—breast cancer	1.31e-06	2.64e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A1—breast cancer	1.3e-06	2.61e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—NOS3—breast cancer	1.29e-06	2.6e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ERCC2—breast cancer	1.29e-06	2.59e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—NOS3—breast cancer	1.28e-06	2.58e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CB—breast cancer	1.26e-06	2.55e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTEN—breast cancer	1.25e-06	2.53e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—breast cancer	1.25e-06	2.52e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—breast cancer	1.24e-06	2.5e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—MTHFR—breast cancer	1.21e-06	2.44e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—breast cancer	1.2e-06	2.42e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CB—breast cancer	1.19e-06	2.4e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CB—breast cancer	1.18e-06	2.38e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—breast cancer	1.18e-06	2.38e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—breast cancer	1.17e-06	2.36e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CD—breast cancer	1.16e-06	2.33e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HRAS—breast cancer	1.15e-06	2.31e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALB—breast cancer	1.14e-06	2.3e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CAV1—breast cancer	1.12e-06	2.25e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL6—breast cancer	1.1e-06	2.21e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—NOS3—breast cancer	1.09e-06	2.2e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTEN—breast cancer	1.09e-06	2.2e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTEN—breast cancer	1.03e-06	2.07e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTEN—breast cancer	1.02e-06	2.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CG—breast cancer	1.02e-06	2.05e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—AKT1—breast cancer	1.01e-06	2.04e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CB—breast cancer	1.01e-06	2.03e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—breast cancer	1e-06	2.01e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CD—breast cancer	8.94e-07	1.8e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—breast cancer	8.85e-07	1.78e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALB—breast cancer	8.82e-07	1.78e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTEN—breast cancer	8.72e-07	1.76e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—NOS3—breast cancer	8.44e-07	1.7e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CB—breast cancer	7.79e-07	1.57e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—breast cancer	7.72e-07	1.55e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—breast cancer	7.71e-07	1.55e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—breast cancer	7.27e-07	1.46e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—AKT1—breast cancer	7.23e-07	1.46e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—breast cancer	7.2e-07	1.45e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTEN—breast cancer	6.73e-07	1.36e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—AKT1—breast cancer	6.3e-07	1.27e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—breast cancer	6.15e-07	1.24e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—AKT1—breast cancer	5.94e-07	1.19e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—AKT1—breast cancer	5.88e-07	1.18e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—AKT1—breast cancer	5.03e-07	1.01e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—breast cancer	4.75e-07	9.56e-06	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—AKT1—breast cancer	3.88e-07	7.81e-06	CbGpPWpGaD
